For suspected cow's milk protein allergy, why is trial use of hydrolyzed or free amino acid containing formula recommended instead of soy-based formula?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

For suspected cow's milk protein allergy, why is trial use of hydrolyzed or free amino acid containing formula recommended instead of soy-based formula?

Explanation:
When suspected cow's milk protein allergy is present, the goal is to feed with a formula that has minimal allergen exposure. A portion of infants with CMPA also have a concurrent allergy to soy protein, so starting with a soy-based formula can provoke or perpetuate allergic reactions in those children. Extensively hydrolyzed formulas break cow milk proteins into small peptides, greatly reducing allergenicity, and amino acid–based formulas contain no intact protein, making them the safest option to assess tolerance and manage symptoms. If soy were used first, you might miss ongoing reactions or misattribute improvement to other factors. The other choices don’t reflect the reason for avoiding soy—growth or cost aren’t the primary clinical concerns here, and soy is not guaranteed to be tolerated by all CMPA patients.

When suspected cow's milk protein allergy is present, the goal is to feed with a formula that has minimal allergen exposure. A portion of infants with CMPA also have a concurrent allergy to soy protein, so starting with a soy-based formula can provoke or perpetuate allergic reactions in those children. Extensively hydrolyzed formulas break cow milk proteins into small peptides, greatly reducing allergenicity, and amino acid–based formulas contain no intact protein, making them the safest option to assess tolerance and manage symptoms. If soy were used first, you might miss ongoing reactions or misattribute improvement to other factors. The other choices don’t reflect the reason for avoiding soy—growth or cost aren’t the primary clinical concerns here, and soy is not guaranteed to be tolerated by all CMPA patients.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy